185
Views
0
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

Platelet/Lymphocyte Ratio Predicted Long-Term Prognosis for Acute Upper Extremity Deep Vein Thrombosis from a Retrospective Study

ORCID Icon, & ORCID Icon
Pages 225-234 | Received 24 Nov 2022, Accepted 10 Jan 2023, Published online: 14 Jan 2023

Figures & data

Figure 1 (A) Intraoperative cavography after placement of an Aegisy vena cava filter placement. Black arrowhead, filter; white arrowhead, superior vena cava. (B) Intraoperative cavography after placement of a Celect vena cava filter. Black arrowhead, filter; white arrowhead, superior vena cava. (C) There was no difference in mortality between groups with and without vena cava filters.

Figure 1 (A) Intraoperative cavography after placement of an Aegisy vena cava filter placement. Black arrowhead, filter; white arrowhead, superior vena cava. (B) Intraoperative cavography after placement of a Celect vena cava filter. Black arrowhead, filter; white arrowhead, superior vena cava. (C) There was no difference in mortality between groups with and without vena cava filters.

Table 1 Clinical Baseline Characteristics

Figure 2 Kaplan–Meier analysis with Log rank test showed significant differences in all-cause mortality between groups with and without malignancy (A), D-dimer≥0.92µg/mL and <1.45µmol/L (B), PLR≥291 and <291 (C), and SII≥1487 and <1487 (D).

Figure 2 Kaplan–Meier analysis with Log rank test showed significant differences in all-cause mortality between groups with and without malignancy (A), D-dimer≥0.92µg/mL and <1.45µmol/L (B), PLR≥291 and <291 (C), and SII≥1487 and <1487 (D).

Table 2 Subgroup Analysis of Patients with Malignancy

Table 3 Comparison Between the Patients with and without Vena Cava Filters